Drug Type mRNA encoding bispecific antibody, Bispecific T-cell Engager (BiTE) |
Synonyms ABO2015 |
Target |
Action inhibitors, modulators |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), CD3 modulators(T cell surface glycoprotein CD3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Phase 1 | China | - |